(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL
文献类型：期刊论文
| 作者 | Yi Shen; Ting Jiang; Rongsheng Wang; Shijun He; Mengru Guo; Jianping Zuo; Dongyi He |
| 刊名 | bmccomplementaryandalternativemedicine
 |
| 出版日期 | 2015 |
| 卷号 | 15期号:1 |
| ISSN号 | 1472-6882 |
| DOI | 10.1186/s12906-015-0566-y |
| 英文摘要 | The aim of this study was to investigate the regulative activity of (5R)-5-hydroxytriptolide (LLDT-8) on receptor activator of nuclear factor κ-B ligand (RANKL)/receptor activator of nuclear factor κ-B (RANK)/Osteoprotegerin (OPG) system in rheumatoid arthritis (RA) and its anti-osteoclastogenesis mechanism. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/280400]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.Shanghai Guanghua Hospital of Integrated Traditional and Western Medicine 2.Arthritis Institute of integrated Traditional and Western medicine, Shanghai Chinese Medicine Research Institute 3.Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
| 推荐引用方式 GB/T 7714 | Yi Shen,Ting Jiang,Rongsheng Wang,et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL[J]. bmccomplementaryandalternativemedicine,2015,15(1). |
| APA | Yi Shen.,Ting Jiang.,Rongsheng Wang.,Shijun He.,Mengru Guo.,...&Dongyi He.(2015).(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL.bmccomplementaryandalternativemedicine,15(1). |
| MLA | Yi Shen,et al."(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL".bmccomplementaryandalternativemedicine 15.1(2015). |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。